Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review)
- Authors:
- Olga Renner
- Markus Burkard
- Holger Michels
- Claudia Vollbracht
- Tobias Sinnberg
- Sascha Venturelli
-
Affiliations: Department of Nutritional Biochemistry, University of Hohenheim, D‑70599 Stuttgart, Germany, Pascoe Pharmazeutische Praeparate GmbH, D‑35394 Giessen, Germany, Department of Dermatology, University Hospital Tuebingen, D‑72076 Tuebingen, Germany - Published online on: May 6, 2021 https://doi.org/10.3892/ijo.2021.5215
- Article Number: 35
-
Copyright: © Renner et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P and Ellison DW: The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD and Tsatsakis A: Current and future trends on diagnosis and prognosis of glioblastoma: From molecular biology to proteomics. Cells. 8:8632019. View Article : Google Scholar : | |
|
Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra M and Falzone L: The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. Oncol Rep. 42:911–922. 2019.PubMed/NCBI | |
|
Armento A, Ehlers J, Schötterl S and Naumann U: Molecular mechanisms of glioma cell motility. Glioblastoma. De Vleeschouwer S: Codon Publications; Brisbane: 2017, View Article : Google Scholar | |
|
Tabatabai G and Wakimoto H: Glioblastoma: State of the Art and future perspectives. Cancers (Basel). 11:10912019. View Article : Google Scholar | |
|
Ohgaki H and Kleihues P: Epidemiology and etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ostrom QT, Gittleman H, Stetson L, Virk S and Barnholtz-Sloan JS: Epidemiology of intracranial gliomas. Prog Neurol Surg. 30:1–11. 2018. View Article : Google Scholar | |
|
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, et al: Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): A randomised, double-blind, international phase 3 trial. Lancet Oncol. 18:1373–1385. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tian M, Ma W, Chen Y, Yu Y, Zhu D, Shi J and Zhang Y: Impact of gender on the survival of patients with glioblastoma. Biosci Rep. Nov 7–2018.Epub ahead of print. View Article : Google Scholar | |
|
Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, et al: cIMPACT-NOW update 3: Recommended diagnostic criteria for 'Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV'. Acta Neuropathol. 136:805–810. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao H, Zhu H, Huang J, Zhu Y, Hong M, Zhu H, Zhang J, Li S, Yang L, Lian Y, et al: The synergy of vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. Leuk Res. 66:1–7. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
García MG, Carella A, Urdinguio RG, Bayón GF, Lopez V, Tejedor JR, Sierra MI, García-Toraño E, Santamarina P, Perez RF, et al: Epigenetic dysregulation of TET2 in human glioblastoma. Oncotarget. 9:25922–25934. 2018. View Article : Google Scholar : | |
|
Mansouri A, Hachem LD, Mansouri S, Nassiri F, Laperriere NJ, Xia D, Lindeman NI, Wen PY, Chakravarti A, Mehta MP, et al: MGMT promoter methylation status testing to guide therapy for glioblastoma: Refining the approach based on emerging evidence and current challenges. Neuro Oncol. 21:167–178. 2019. View Article : Google Scholar : | |
|
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F and Reulen HJ; ALA-Glioma Study Group: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol. 7:392–401. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Pichlmeier U, Bink A and Schackert G: Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol. 10:1025–1034. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Abd-El-Barr MM and Chiocca EA: How much is enough? The question of extent of resection in glioblastoma multiforme. World Neurosurg. 82:e109–e110. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ryken TC, Parney I, Buatti J, Kalkanis SN and Olson JJ: The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. J Neurooncol. 125:551–583. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, Grosu AL, Lagerwaard FJ, Minniti G, Mirimanoff RO, et al: ESTRO-ACROP guideline 'target delineation of glioblastomas'. Radiother Oncol. 118:35–42. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, et al: Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: The NOA-08 randomised, phase 3 trial. Lancet Oncol. 13:707–715. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rusthoven CG, Koshy M and Sher DJ: Radiation plus temozolomide in patients with glioblastoma. N Engl J Med. 376:2195–2197. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Perry JR, Laperriere N, O'Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, et al: Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med. 376:1027–1037. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
McGranahan T, Therkelsen KE, Ahmad S and Nagpal S: Current state of immunotherapy for treatment of glioblastoma. Curr Treat Options Oncol. 20:242019. View Article : Google Scholar : PubMed/NCBI | |
|
Rominiyi O, Vanderlinden A, Clenton SJ, Bridgewater C, Al-Tamimi Y and Collis SJ: Tumour treating fields therapy for glioblastoma: Current advances and future directions. Br J Cancer. 124:697–709. 2021. View Article : Google Scholar | |
|
Geletneky K, Hajda J, Angelova AL, Leuchs B, Capper D, Bartsch AJ, Neumann JO, Schöning T, Hüsing J, Beelte B, et al: Oncolytic H-1 parvovirus shows safety and signs of immunogenic activity in a first phase I/IIa glioblastoma trial. Mol Ther. 25:2620–2634. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E and Levine M: Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a prodrug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA. 102:13604–13609. 2005. View Article : Google Scholar | |
|
Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR and Levine M: Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA. 104:8749–8754. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, et al: O2− and H2O2-mediated disruption of fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell. 32:2682017. View Article : Google Scholar | |
|
Klingelhoeffer C, Kämmerer U, Koospal M, Mühling B, Schneider M, Kapp M, Kübler A, Germer CT and Otto C: Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress. BMC Complement Altern Med. 12:612012. View Article : Google Scholar : PubMed/NCBI | |
|
Sauberlich HE: Pharmacology of vitamin C. Annu Rev Nutr. 14:371–391. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Nishikimi M and Yagi K: Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am J Clin Nutr. 54(Suppl 6): 1203S–1208S. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Padayatty SJ and Levine M: Vitamin C: The known and the unknown and goldilocks. Oral Dis. 22:463–493. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Carr A and Frei B: Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J. 13:1007–1024. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Levine M, Wang Y, Katz A, Eck P, Kwon O, Chen S, Lee JH and Padayatty SJ: Ideal vitamin C intake. Biofactors. 15:71–74. 2001. View Article : Google Scholar | |
|
Carr AC and Lykkesfeldt J: Discrepancies in global vitamin C recommendations: A review of RDA criteria and underlying health perspectives. Crit Rev Food Sci Nutr. 61:742–755. 2021. View Article : Google Scholar | |
|
Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J and Cantilena LR: Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sci USA. 93:3704–3709. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L and Miller WH Jr: Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol. 19:1969–1974. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J and Levine M: Vitamin C: Intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 5:e114142010. View Article : Google Scholar : PubMed/NCBI | |
|
Nielsen TK, Højgaard M, Andersen JT, Poulsen HE, Lykkesfeldt J and Mikines KJ: Elimination of ascorbic acid after high-dose infusion in prostate cancer patients: A pharmacokinetic evaluation. Basic Clin Pharmacol Toxicol. 116:343–348. 2015. View Article : Google Scholar | |
|
Stephenson CM, Levin RD, Spector T and Lis CG: Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol. 72:139–146. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Torun M, Yardim S, Gönenç A, Sargin H, Menevşe A and Símşek B: Serum beta-carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer. J Clin Pharm Ther. 20:259–263. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Mahdavi R, Faramarzi E, Seyedrezazadeh E, Mohammad-Zadeh M and Pourmoghaddam M: Evaluation of oxidative stress, antioxidant status and serum vitamin C levels in cancer patients. Biol Trace Elem Res. 130:1–6. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma A, Tripathi M, Satyam A and Kumar L: Study of antioxidant levels in patients with multiple myeloma. Leuk Lymphoma. 50:809–815. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Emri S, Kilickap S, Kadilar C, Halil MG, Akay H and Besler T: Serum levels of alpha-tocopherol, vitamin C, beta-carotene, and retinol in malignant pleural mesothelioma. Asian Pac J Cancer Prev. 13:3025–3029. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mehdi WA, Zainulabdeen JA and Mehde AA: Investigation of the antioxidant status in multiple myeloma patients: Effects of therapy. Asian Pac J Cancer Prev. 14:3663–3667. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Huijskens MJ, Wodzig WK, Walczak M, Germeraad WT and Bos GM: Ascorbic acid serum levels are reduced in patients with hematological malignancies. Results Immunol. 6:8–10. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fain O, Mathieu E and Thomas M: Scurvy in patients with cancer. BMJ. 316:1661–1662. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Mayland CR, Bennett MI and Allan K: Vitamin C deficiency in cancer patients. Palliat Med. 19:17–20. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N and Rivera A: Intravenous vitamin C as a chemo-therapy agent: A report on clinical cases. P R Health Sci J. 23:115–118. 2004.PubMed/NCBI | |
|
Hoffer LJ, Robitaille L, Zakarian R, Melnychuk D, Kavan P, Agulnik J, Cohen V, Small D and Miller WH Jr: High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: A phase I-II clinical trial. PLoS One. 10:e01202282015. View Article : Google Scholar : PubMed/NCBI | |
|
Liu M, Ohtani H, Zhou W, Ørskov AD, Charlet J, Zhang YW, Shen H, Baylin SB, Liang G, Grønbæk K and Jones PA: Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine. Proc Natl Acad Sci USA. 113:10238–10244. 2016. View Article : Google Scholar | |
|
Shenoy N, Bhagat T, Nieves E, Stenson M, Lawson J, Choudhary GS, Habermann T, Nowakowski G, Singh R, Wu X, et al: Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells. Blood Cancer J. 7:e5872017. View Article : Google Scholar : PubMed/NCBI | |
|
Anthony HM and Schorah CJ: Severe hypovitaminosis C in lung-cancer patients: The utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer. 46:354–367. 1982. View Article : Google Scholar : PubMed/NCBI | |
|
Ramaswamy G and Krishnamoorthy L: Serum carotene, vitamin A, and vitamin C levels in breast cancer and cancer of the uterine cervix. Nutr Cancer. 25:173–177. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Khanzode SS, Muddeshwar MG, Khanzode SD and Dakhale GN: Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic Res. 38:81–85. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Popa-Wagner A, Mitran S, Sivanesan S, Chang E and Buga AM: ROS and brain diseases: The good, the bad, and the ugly. Oxid Med Cell Longev. 2013:9635202013. View Article : Google Scholar | |
|
Levine M, Padayatty SJ and Espey MG: Vitamin C: A concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2:78–88. 2011. View Article : Google Scholar : | |
|
Du J, Cullen JJ and Buettner GR: Ascorbic acid: Chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 1826:443–457. 2012.PubMed/NCBI | |
|
Harrison FE and May JM: Vitamin C function in the brain: Vital role of the ascorbate transporter SVCT2. Free Radic Biol Med. 46:719–730. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kaźmierczak-Barańska J, Boguszewska K, Adamus-Grabicka A and Karwowski BT: Two faces of vitamin C-antioxidative and pro-oxidative agent. Nutrients. 12:15012020. View Article : Google Scholar | |
|
Lykkesfeldt J and Tveden-Nyborg P: The pharmacokinetics of vitamin C. Nutrients. 11:24122019. View Article : Google Scholar : | |
|
Abbott NJ: Dynamics of CNS barriers: Evolution, differentiation, and modulation. Cell Mol Neurobiol. 25:5–23. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Nualart F, Mack L, García A, Cisternas P, Bongarzone ER, Heitzer M, Jara N, Martínez F, Ferrada L, Espinoza F, et al: Vitamin C transporters, recycling and the bystander effect in the nervous system: SVCT2 versus gluts. J Stem Cell Res Ther. 4:2092014. View Article : Google Scholar : PubMed/NCBI | |
|
Angelow S, Haselbach M and Galla HJ: Functional characterisation of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroid plexus cells. Brain Res. 988:105–113. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Haselbach M, Wegener J, Decker S, Engelbertz C and Galla HJ: Porcine choroid plexus epithelial cells in culture: Regulation of barrier properties and transport processes. Microsc Res Tech. 52:137–152. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Shi LZ, Li GJ, Wang S and Zheng W: Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: Tight junction proteins and transport properties. Toxicol In Vitro. 22:190–199. 2008. View Article : Google Scholar | |
|
Strazielle N and Ghersi-Egea JF: Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci. 19:6275–6289. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Sotiriou S, Gispert S, Cheng J, Wang Y, Chen A, Hoogstraten-Miller S, Miller GF, Kwon O, Levine M, Guttentag SH and Nussbaum RL: Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med. 8:514–517. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Tsukaguchi H, Tokui T, Mackenzie B, Berger UV, Chen XZ, Wang Y, Brubaker RF and Hediger MA: A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature. 399:70–75. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Daruwala R, Song J, Koh WS, Rumsey SC and Levine M: Cloning and functional characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2. FEBS Lett. 460:480–484. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH and Franceschi RT: Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res. 14:893–903. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Mackenzie B, Tsukaguchi H, Weremowicz S, Morton CC and Hediger MA: Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem Biophys Res Commun. 267:488–494. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Wohlrab C, Phillips E and Dachs GU: Vitamin C transporters in cancer: Current understanding and gaps in knowledge. Front Oncol. 7:742017. View Article : Google Scholar : PubMed/NCBI | |
|
Agus DB, Gambhir SS, Pardridge WM, Spielholz C, Baselga J, Vera JC and Golde DW: Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest. 100:2842–2848. 1997. View Article : Google Scholar | |
|
Ho HTB, Dahlin A and Wang J: Expression profiling of solute carrier gene families at the blood-CSF barrier. Front Pharmacol. 3:1542012. View Article : Google Scholar : PubMed/NCBI | |
|
Bürzle M, Suzuki Y, Ackermann D, Miyazaki H, Maeda N, Clémençon B, Burrier R and Hediger MA: The sodium-dependent ascorbic acid transporter family SLC23. Mol Aspects Med. 34:436–454. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rice ME: Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23:209–216. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Spector R, Keep RF, Robert Snodgrass S, Smith QR and Johanson CE: A balanced view of choroid plexus structure and function: Focus on adult humans. Exp Neurol. 267:78–86. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mun GH, Kim MJ, Lee JH, Kim HJ, Chung YH, Chung YB, Kang JS, Hwang YI, Oh SH, Kim JG, et al: Immunohistochemical study of the distribution of sodium-dependent vitamin C trans-porters in adult rat brain. J Neurosci Res. 83:919–928. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ulloa V, García-Robles M, Martínez F, Salazar K, Reinicke K, Pérez F, Godoy DF, Godoy AS and Nualart F: Human choroid plexus papilloma cells efficiently transport glucose and vitamin C. J Neurochem. 127:403–414. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rice M and Russo-Menna I: Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience. 82:1213–1223. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Castro M, Caprile T, Astuya A, Millán C, Reinicke K, Vera JC, Vásquez O, Aguayo LG and Nualart F: High-affinity sodium-vitamin C co-transporters (SVCT) expression in embryonic mouse neurons. J Neurochem. 78:815–823. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Nualart FJ, Rivas CI, Montecinos VP, Godoy AS, Guaiquil VH, Golde DW and Vera JC: Recycling of vitamin C by a bystander effect. J Biol Chem. 278:10128–10133. 2003. View Article : Google Scholar | |
|
Kaufman S: Coenzymes and hydroxylases: Ascorbate and dopamine-beta-hydroxylase; tetrahydropteridines and phenyl-alanine and tyrosine hydroxylases. Pharmacol Rev. 18:61–69. 1966.PubMed/NCBI | |
|
Eipper BA, Milgram SL, Husten EJ, Yun HY and Mains RE: Peptidylglycine alpha-amidating monooxygenase: A multifunctional protein with catalytic, processing, and routing domains. Protein Sci. 2:489–497. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Eldridge CF, Bunge MB, Bunge RP and Wood PM: Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol. 105:1023–1034. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu S, Li L, Weeber EJ and May JM: Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J Neurosci Res. 85:1046–1056. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Rebec GV and Pierce RC: A vitamin as neuromodulator: Ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog Neurobiol. 43:537–565. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Pastor P, Cisternas P, Salazar K, Silva-Alvarez C, Oyarce K, Jara N, Espinoza F, Martínez AD and Nualart F: SVCT2 vitamin C transporter expression in progenitor cells of the post-natal neurogenic niche. Front Cell Neurosci. 7:1192013. View Article : Google Scholar | |
|
Oyarce K, Bongarzone ER and Nualart F: Unconventional neurogenic niches and neurogenesis modulation by vitamins. J Stem Cell Res Ther. 4:1842014.PubMed/NCBI | |
|
Davson H and Oldendorf WH: Symposium on membrane transport. Transport in the central nervous system. Proc R Soc Med. 60:326–329. 1967.PubMed/NCBI | |
|
Reiber H, Ruff M and Uhr M: Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate. Clinica Chimica Acta. 217:163–173. 1993. View Article : Google Scholar | |
|
Cameron E and Pauling L: Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA. 73:3685–3689. 1976. View Article : Google Scholar : PubMed/NCBI | |
|
Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J and Frytak S: Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 301:687–690. 1979. View Article : Google Scholar : PubMed/NCBI | |
|
Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ and Ames MM: High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 312:137–141. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, Pillai MV, Newberg AB, Deshmukh S and Levine M: Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One. 7:e297942012. View Article : Google Scholar : PubMed/NCBI | |
|
Welsh JL, Wagner BA, van't Erve TJ, Zehr PS, Berg DJ, Halfdanarson TR, Yee NS, Bodeker KL, Du J, Roberts LJ II, et al: Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): Results from a phase I clinical trial. Cancer Chemother Pharmacol. 71:765–775. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Herst PM, Broadley KWR, Harper JL and McConnell MJ: Pharmacological concentrations of ascorbate radiosensitize glio-blastoma multiforme primary cells by increasing oxidative DNA damage and inhibiting G2/M arrest. Free Radic Biol Med. 52:1486–1493. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ma Y, Chapman J, Levine M, Polireddy K, Drisko J and Chen Q: High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 6:222ra182014. View Article : Google Scholar : PubMed/NCBI | |
|
Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, Skidmore B, Kirchner L and Seely D: Intravenous vitamin C and cancer: A systematic review. Integr Cancer Ther. 13:280–300. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Carr AC and Cook J: Intravenous vitamin C for cancer therapy-identifying the current gaps in our knowledge. Front Physiol. 9:11822018. View Article : Google Scholar | |
|
Violet PC and Levine M: Pharmacologic ascorbate in myeloma treatment: Doses matter. EBioMedicine. 18:9–10. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Schoenfeld JD, Alexander MS, Waldron TJ, Sibenaller ZA, Spitz DR, Buettner GR, Allen BG and Cullen JJ: Pharmacological ascorbate as a means of sensitizing cancer cells to radio-chemo-therapy while protecting normal tissue. Semin Radiat Oncol. 29:25–32. 2019. View Article : Google Scholar | |
|
Bienert GP, Schjoerring JK and Jahn TP: Membrane transport of hydrogen peroxide. Biochim Biophys Acta. 1758:994–1003. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Bienert GP, Møller AL, Kristiansen KA, Schulz A, Møller IM, Schjoerring JK and Jahn TP: Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem. 282:1183–1192. 2007. View Article : Google Scholar | |
|
Erudaitius D, Huang A, Kazmi S, Buettner GR and Rodgers VG: Peroxiporin expression is an important factor for cancer cell susceptibility to therapeutic H2O2: Implications for pharmacological ascorbate therapy. PLoS One. 12:e01704422017. View Article : Google Scholar | |
|
Deubzer B, Mayer F, Kuçi Z, Niewisch M, Merkel G, Handgretinger R and Bruchelt G: H(2)O(2)-mediated cytotoxicity of pharmacologic ascorbate concentrations to neuroblastoma cells: Potential role of lactate and ferritin. Cell Physiol Biochem. 25:767–774. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Olney KE, Du J, van 't Erve TJ, Witmer JR, Sibenaller ZA, Wagner BA, Buettner GR and Cullen JJ: Inhibitors of hydroperoxide metabolism enhance ascorbate-induced cytotoxicity. Free Radic Res. 47:154–163. 2013. View Article : Google Scholar : | |
|
Du J, Martin SM, Levine M, Wagner BA, Buettner GR, Wang S, Taghiyev AF, Du C, Knudson CM and Cullen JJ: Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res. 16:509–520. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ibrahim WH, Habib HM, Kamal H, St Clair DK and Chow CK: Mitochondrial superoxide mediates labile iron level: Evidence from Mn-SOD-transgenic mice and heterozygous knockout mice and isolated rat liver mitochondria. Free Radic Biol Med. 65:143–149. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Doskey CM, Buranasudja V, Wagner BA, Wilkes JG, Du J, Cullen JJ and Buettner GR: Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy. Redox Biol. 10:274–284. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sinnberg T, Noor S, Venturelli S, Berger A, Schuler P, Garbe C and Busch C: The ROS-induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF-1alpha in the NCI60 cancer cell lines. J Cell Mol Med. 18:530–541. 2014. View Article : Google Scholar : | |
|
Du J, Cieslak JA III, Welsh JL, Sibenaller ZA, Allen BG, Wagner BA, Kalen AL, Doskey CM, Strother RK, Button AM, et al: Pharmacological ascorbate radiosensitizes pancreatic cancer. Cancer Res. 75:3314–3326. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Torti SV and Torti FM: Iron and cancer: More ore to be mined. Nat Rev Cancer. 13:342–355. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Uetaki M, Tabata S, Nakasuka F, Soga T and Tomita M: Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress. Sci Rep. 5:138962015. View Article : Google Scholar : PubMed/NCBI | |
|
El Banna N, Hatem E, Heneman-Masurel A, Léger T, Baïlle D, Vernis L, Garcia C, Martineau S, Dupuy C, Vagner S, et al: Redox modifications of cysteine-containing proteins, cell cycle arrest and translation inhibition: Involvement in vitamin C-induced breast cancer cell death. Redox Biol. 26:1012902019. View Article : Google Scholar : PubMed/NCBI | |
|
Frömberg A, Gutsch D, Schulze D, Vollbracht C, Weiss G, Czubayko F and Aigner A: Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs. Cancer Chemother Pharmacol. 67:1157–1166. 2011. View Article : Google Scholar : | |
|
Marklund SL, Westman NG, Lundgren E and Roos G: Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res. 42:1955–1961. 1982.PubMed/NCBI | |
|
Johnson RM, Ho YS, Yu DY, Kuypers FA, Ravindranath Y and Goyette GW: The effects of disruption of genes for peroxire-doxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic Biol Med. 48:519–525. 2010. View Article : Google Scholar | |
|
Vaupel P, Höckel M and Mayer A: Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal. 9:1221–1235. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Moulder JE and Rockwell S: Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys. 10:695–712. 1984. View Article : Google Scholar : PubMed/NCBI | |
|
Vaupel P, Mayer A and Höckel M: Tumor hypoxia and malignant progression. Methods Enzymol. 381:335–354. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng W, Liu P, Pan W, Singh SR and Wei Y: Hypoxia and hypoxia inducible factors in tumor metabolism. Cancer Lett. 356:263–267. 2015. View Article : Google Scholar | |
|
Korkolopoulou P, Patsouris E, Konstantinidou AE, Pavlopoulos PM, Kavantzas N, Boviatsis E, Thymara I, Perdiki M, Thomas-Tsagli E, Angelidakis D, et al: Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol. 30:267–278. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Mashiko R, Takano S, Ishikawa E, Yamamoto T, Nakai K and Matsumura A: Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image. J Neurooncol. 102:43–50. 2011. View Article : Google Scholar | |
|
Søndergaard KL, Hilton DA, Penney M, Ollerenshaw M and Demaine AG: Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma. Neuropathol Appl Neurobiol. 28:210–217. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Bao L, Chen Y, Lai HT, Wu SY, Wang JE, Hatanpaa KJ, Raisanen JM, Fontenot M, Lega B, Chiang CM, et al: Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration. Nucleic Acids Res. 46:6576–6591. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Campbell EJ, Dachs GU, Morrin HR, Davey VC, Robinson BA and Vissers MCM: Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels. BMC Cancer. 19:3072019. View Article : Google Scholar : PubMed/NCBI | |
|
Camarena V and Wang G: The epigenetic role of vitamin C in health and disease. Cell Mol Life Sci. 73:1645–1658. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Satheesh NJ, Samuel SM and Büsselberg D: Combination therapy with vitamin c could eradicate cancer stem cells. Biomolecules. 10:792020. View Article : Google Scholar : | |
|
O'Leary BR, Houwen FK, Johnson CL, Allen BG, Mezhir JJ, Berg DJ, Cullen JJ and Spitz DR: Pharmacological ascorbate as an adjuvant for enhancing radiation-chemotherapy responses in gastric adenocarcinoma. Radiat Res. 189:456–465. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Espey MG, Chen P, Chalmers B, Drisko J, Sun AY, Levine M and Chen Q: Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med. 50:1610–1619. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Moser JC, Rawal M, Wagner BA, Du J, Cullen JJ and Buettner GR: Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer. Redox Biol. 2:22–27. 2013. View Article : Google Scholar | |
|
Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J and Levine M: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA. 105:11105–11109. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lu YX, Wu QN, Chen DL, Chen LZ, Wang ZX, Ren C, Mo HY, Chen Y, Sheng H, Wang YN, et al: Pharmacological ascorbate suppresses growth of gastric cancer cells with GLUT1 overexpression and enhances the efficacy of oxaliplatin through redox modulation. Theranostics. 8:1312–1326. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Oka N, Komuro A, Amano H, Dash S, Honda M, Ota K, Nishimura S, Ueda T, Akagi M and Okada H: Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin. Pharmacol Res Perspect. 8:e006322020. View Article : Google Scholar : PubMed/NCBI | |
|
Kanter M and Akpolat M: Vitamin C protects against ionizing radiation damage to goblet cells of the ileum in rats. Acta Histochem. 110:481–490. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ito Y, Kinoshita M, Yamamoto T, Sato T, Obara T, Saitoh D, Seki S and Takahashi Y: A combination of pre- and post-exposure ascorbic acid rescues mice from radiation-induced lethal gastrointestinal damage. Int J Mol Sci. 14:19618–19635. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Vollbracht C, Schneider B, Leendert V, Weiss G, Auerbach L and Beuth J: Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: Results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo. 25:983–990. 2011.PubMed/NCBI | |
|
Polireddy K, Dong R, Reed G, Yu J, Chen P, Williamson S, Violet PC, Pessetto Z, Godwin AK, Fan F, et al: High dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: Mechanisms and a phase I/IIa study. Sci Rep. 7:171882017. View Article : Google Scholar : PubMed/NCBI | |
|
Nauman G, Gray JC, Parkinson R, Levine M and Paller CJ: Systematic review of intravenous ascorbate in cancer clinical trials. Antioxidants (Basel). 7:892018. View Article : Google Scholar | |
|
Nielsen TK, Højgaard M, Andersen JT, Jørgensen NR, Zerahn B, Kristensen B, Henriksen T, Lykkesfeldt J, Mikines KJ and Poulsen HE: Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: A single-arm phase II trial. Transl Androl Urol. 6:517–528. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang F, He MM, Wang ZX, Li S, Jin Y, Ren C, Shi SM, Bi BT, Chen SZ, Lv ZD, et al: Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer. BMC Cancer. 19:4602019. View Article : Google Scholar : PubMed/NCBI | |
|
Alexander MS, Wilkes JG, Schroeder SR, Buettner GR, Wagner BA, Du J, Gibson-Corley K, O'Leary BR, Spitz DR, Buatti JM, et al: Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer. Cancer Res. 78:6838–6851. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ou J, Zhu X, Chen P, Du Y, Lu Y, Peng X, Bao S, Wang J, Zhang X, Zhang T and Pang CLK: A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer. J Adv Res. 24:175–182. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Allen BG, Bodeker KL, Smith MC, Monga V, Sandhu S, Hohl R, Carlisle T, Brown H, Hollenbeck N, Vollstedt S, et al: First-in-human phase I clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma. Clin Cancer Res. 25:6590–6597. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Baillie N, Carr AC and Peng S: The use of intravenous vitamin C as a supportive therapy for a patient with glioblastoma multiforme. Antioxidants (Basel). 7:1152018. View Article : Google Scholar | |
|
Cushing CM, Petronek MS, Bodeker KL, Vollstedt S, Brown HA, Opat E, Hollenbeck NJ, Shanks T, Berg DJ, Smith BJ, et al: Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy. Redox Biol. 38:1018042021. View Article : Google Scholar | |
|
Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA and Levine M: Vitamin C pharmacokinetics: Implications for oral and intravenous use. Ann Intern Med. 140:533–537. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Fowler AA III, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, Larus TL, Martin E, Brophy DF, et al: Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 12:322014. View Article : Google Scholar : PubMed/NCBI | |
|
Zabet MH, Mohammadi M, Ramezani M and Khalili H: Effect of high-dose ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm Pract. 5:94–100. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H and Shimazaki S: Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: A randomized, prospective study. Arch Surg. 135:326–331. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Li G, Qin Z, Chen Z, Xie L, Wang R and Zhao H: Tumor microenvironment in treatment of glioma. Open Med (Wars). 12:247–251. 2017. View Article : Google Scholar | |
|
Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, et al: Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 330:841–845. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Charles NA, Holland EC, Gilbertson R, Glass R and Kettenmann H: The brain tumor microenvironment. Glia. 60:502–514. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Poon CC, Sarkar S, Yong VW and Kelly JJP: Glioblastoma-associated microglia and macrophages: Targets for therapies to improve prognosis. Brain. 140:1548–1560. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Poon CC, Gordon PMK, Liu K, Yang R, Sarkar S, Mirzaei R, Ahmad ST, Hughes ML, Yong VW and Kelly JJP: Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma. Oncotarget. 10:3129–3143. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Tomaszewski W, Sanchez-Perez L, Gajewski TF and Sampson JH: Brain tumor microenvironment and host state: Implications for immunotherapy. Clin Cancer Res. 25:4202–4210. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hwang SY, Yoo BC, Jung J, Oh ES, Hwang JS, Shin JA, Kim SY, Cha SH and Han IO: Induction of glioma apoptosis by microglia-secreted molecules: The role of nitric oxide and cathepsin B. Biochim Biophys Acta. 1793:1656–1668. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chicoine MR, Zahner M, Won EK, Kalra RR, Kitamura T, Perry A and Higashikubo R: The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4. Neurosurgery. 60:372–381. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Martins TA, Schmassmann P, Shekarian T, Boulay JL, Ritz MF, Zanganeh S, vom Berg J and Hutter G: Microglia-centered combinatorial strategies against glioblastoma. Front Immunol. 11:5719512020. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta K and Burns TC: Radiation-induced alterations in the recurrent glioblastoma microenvironment: Therapeutic implications. Front Oncol. 8:5032018. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshimura M, Itasaka S, Harada H and Hiraoka M: Micro-environment and radiation therapy. Biomed Res Int. 2013:6853082013. View Article : Google Scholar | |
|
Bellail AC, Hunter SB, Brat DJ, Tan C and van Meir EG: Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol. 36:1046–1069. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wild-Bode C, Weller M, Rimner A, Dichgans J and Wick W: Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma. Cancer Res. 61:2744–2750. 2001.PubMed/NCBI | |
|
Shankar A, Kumar S, Iskander AS, Varma NR, Janic B, deCarvalho A, Mikkelsen T, Frank JA, Ali MM, Knight RA, et al: Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo. Chin J Cancer. 33:148–158. 2014. View Article : Google Scholar : | |
|
Wank M, Schilling D, Reindl J, Meyer B, Gempt J, Motov S, Alexander F, Wilkens JJ, Schlegel J, Schmid TE and Combs SE: Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: Impact of different radiation qualities with differing LET. J Neurooncol. 139:583–590. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wank M, Schilling D, Schmid TE, Meyer B, Gempt J, Barz M, Schlegel J, Liesche F, Kessel KA, Wiestler B, et al: Human glioma migration and infiltration properties as a target for personalized radiation medicine. Cancers (Basel). 10:4562018. View Article : Google Scholar | |
|
Zhang X, Wang X, Xu R, Ji J, Xu Y, Han M, Wei Y, Huang B, Chen A, Zhang Q, et al: YM155 decreases radiation-induced invasion and reverses epithelial-mesenchymal transition by targeting STAT3 in glioblastoma. J Transl Med. 16:792018. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta K, Vuckovic I, Zhang S, Xiong Y, Carlson BL, Jacobs J, Olson I, Petterson XM, Macura SI, Sarkaria J and Burns TC: Radiation induced metabolic alterations associate with tumor aggressiveness and poor outcome in glioblastoma. Front Oncol. 10:5352020. View Article : Google Scholar : PubMed/NCBI | |
|
Dixit S, Bernardo A, Walker JM, Kennard JA, Kim GY, Kessler ES and Harrison FE: Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice. ACS Chem Neurosci. 6:570–581. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Portugal CC, Socodato R and Relvas JB: The ascorbate transporter SVCT2 to target microglia-dependent inflammation. Oncotarget. 8:99217–99218. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Azzolini C, Fiorani M, Cerioni L, Guidarelli A and Cantoni O: Sodium-dependent transport of ascorbic acid in U937 cell mitochondria. IUBMB Life. 65:149–153. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Muñoz-Montesino C, Roa FJ, Peña E, González M, Sotomayor K, Inostroza E, Muñoz CA, González I, Maldonado M, Soliz C, et al: Mitochondrial ascorbic acid transport is mediated by a low-affinity form of the sodium-coupled ascorbic acid transporter-2. Free Radic Biol Med. 70:241–254. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Peña E, Roa FJ, Inostroza E, Sotomayor K, González M, Gutierrez-Castro FA, Maurin M, Sweet K, Labrousse C, Gatica M, et al: Increased expression of mitochondrial sodium-coupled ascorbic acid transporter-2 (mitSVCT2) as a central feature in breast cancer. Free Radic Biol Med. 135:283–292. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Roa FJ, Peña E, Gatica M, Escobar-Acuña K, Saavedra P, Maldonado M, Cuevas ME, Moraga-Cid G, Rivas CI and Muñoz-Montesino C: Therapeutic use of vitamin C in cancer: Physiological considerations. Front Pharmacol. 11:2112020. View Article : Google Scholar : PubMed/NCBI | |
|
McCaffrey G, Staatz WD, Quigley CA, Nametz N, Seelbach MJ, Campos CR, Brooks TA, Egleton RD and Davis TP: Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem. 103:2540–2555. 2007.PubMed/NCBI | |
|
Kook SY, Lee KM, Kim Y, Cha MY, Kang S, Baik SH, Lee H, Park R and Mook-Jung I: High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice. Cell Death Dis. 5:e10832014. View Article : Google Scholar : PubMed/NCBI | |
|
Dubois LG, Campanati L, Righy C, D'Andrea-Meira I, Spohr TC, Porto-Carreiro I, Pereira CM, Balça-Silva J, Kahn SA, DosSantos MF, et al: Gliomas and the vascular fragility of the blood brain barrier. Front Cell Neurosci. 8:4182014. View Article : Google Scholar | |
|
Prata C, Hrelia S and Fiorentini D: Peroxiporins in cancer. Int J Mol Sci. 20:13712019. View Article : Google Scholar : | |
|
Henzler T and Steudle E: Transport and metabolic degradation of hydrogen peroxide in Chara corallina: Model calculations and measurements with the pressure probe suggest transport of H(2)O(2) across water channels. J Exp Bot. 51:2053–2066. 2000. View Article : Google Scholar | |
|
Noell S, Ritz R, Wolburg-Buchholz K, Wolburg H and Fallier-Becker P: An allograft glioma model reveals the depen-dence of aquaporin-4 expression on the brain microenvironment. PLoS One. 7:e365552012. View Article : Google Scholar | |
|
Warth A, Kröger S and Wolburg H: Redistribution of aqua-porin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol. 107:311–318. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL, Lee K, Gullans SR, Mapstone TB and Benos DJ: Differential gene expression profiling in human brain tumors. Physiol Genomics. 5:21–33. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Papadopoulos MC and Saadoun S: Key roles of aquaporins in tumor biology. Biochim Biophys Acta. 1848:2576–2583. 2015. View Article : Google Scholar | |
|
Labak CM, Wang PY, Arora R, Guda MR, Asuthkar S, Tsung AJ and Velpula KK: Glucose transport: Meeting the metabolic demands of cancer, and applications in glioblastoma treatment. Am J Cancer Res. 6:1599–1608. 2016.PubMed/NCBI | |
|
Castro MA, Pozo M, Cortés C, García Mde L, Concha II and Nualart F: Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes. J Neurochem. 102:773–782. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Azzalin A, Nato G, Parmigiani E, Garello F, Buffo A and Magrassi L: Inhibitors of GLUT/SLC2A enhance the action of BCNU and temozolomide against high-grade gliomas. Neoplasia. 19:364–373. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Astuya A, Caprile T, Castro M, Salazar K, García Mde L, Reinicke K, Rodríguez F, Vera JC, Millán C, Ulloa V, et al: Vitamin C uptake and recycling among normal and tumor cells from the central nervous system. J Neurosci Res. 79:146–156. 2005. View Article : Google Scholar | |
|
Chen S, Roffey DM, Dion CA, Arab A and Wai EK: Effect of perioperative vitamin C supplementation on postoperative pain and the incidence of chronic regional pain syndrome: A systematic review and meta-analysis. Clin J Pain. 32:179–185. 2016. View Article : Google Scholar | |
|
Salazar K, Martínez F, Pérez-Martín M, Cifuentes M, Trigueros L, Ferrada L, Espinoza F, Saldivia N, Bertinat R, Forman K, et al: SVCT2 expression and function in reactive astrocytes is a common event in different brain pathologies. Mol Neurobiol. 55:5439–5452. 2018. View Article : Google Scholar | |
|
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, et al: Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14:388–405. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Berger UV, Lu XC, Liu W, Tang Z, Slusher BS and Hediger MA: Effect of middle cerebral artery occlusion on mRNA expression for the sodium-coupled vitamin C transporter SVCT2 in rat brain. J Neurochem. 86:896–906. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Savini I, Rossi A, Catani MV, Ceci R and Avigliano L: Redox regulation of vitamin C transporter SVCT2 in C2C12 myotubes. Biochem Biophys Res Commun. 361:385–390. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Reuter S, Gupta SC, Chaturvedi MM and Aggarwal BB: Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 49:1603–1616. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Harris HR, Orsini N and Wolk A: Vitamin C and survival among women with breast cancer: A meta-analysis. Eur J Cancer. 50:1223–1231. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wilson MK, Baguley BC, Wall C, Jameson MB and Findlay MP: Review of high-dose intravenous vitamin C as an anticancer agent. Asia Pac J Clin Oncol. 10:22–37. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hunnisett A, Davies S, McLaren-Howard J, Gravett P, Finn M and Gueret-Wardle D: Lipoperoxides as an index of free radical activity in bone marrow transplant recipients. Preliminary observations. Biol Trace Elem Res. 47:125–132. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Nan-Ya K, Kajihara M, Kojima N and Degawa M: Usefulness of urinary kidney injury molecule-1 (Kim-1) as a biomarker for cisplatin-induced sub-chronic kidney injury. J Appl Toxicol. 35:124–132. 2015. View Article : Google Scholar | |
|
Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, et al: O2− and H2O2-mediated disruption of fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell. 31:487–500.e8. 2017. View Article : Google Scholar | |
|
Attia M, Essa EA, Zaki RM and Elkordy AA: An overview of the antioxidant effects of ascorbic acid and alpha lipoic acid (in liposomal forms) as adjuvant in cancer treatment. Antioxidants (Basel). 9:3592020. View Article : Google Scholar | |
|
Milletti F: Cell-penetrating peptides: Classes, origin, and current landscape. Drug Discov Today. 17:850–860. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hultqvist G, Syvänen S, Fang XT, Lannfelt L and Sehlin D: Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor. Theranostics. 7:308–318. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Staquicini FI, Ozawa MG, Moya CA, Driessen WH, Barbu EM, Nishimori H, Soghomonyan S, Flores LG, Liang X II, Paolillo V, et al: Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 121:161–173. 2011. View Article : Google Scholar : | |
|
Tong HI, Kang W, Davy PM, Shi Y, Sun S, Allsopp RC and Lu Y: Monocyte trafficking, engraftment, and delivery of nanoparticles and an exogenous gene into the acutely inflamed brain tissue-evaluations on monocyte-based delivery system for the central nervous system. PLoS One. 11:e01540222016. View Article : Google Scholar | |
|
Di Tacchio M, Macas J, Weissenberger J, Sommer K, Bähr O, Steinbach JP, Senft C, Seifert V, Glas M, Herrlinger U, et al: Tumor vessel normalization, immunostimulatory reprogramming, and improved survival in glioblastoma with combined inhibition of PD-1, angiopoietin-2, and VEGF. Cancer Immunol Res. 7:1910–1927. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Przystal JM, Waramit S, Pranjol MZI, Yan W, Chu G, Chongchai A, Samarth G, Olaciregui NG, Tabatabai G, Carcaboso AM, et al: Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma. EMBO Mol Med. 11:e84922019. View Article : Google Scholar : PubMed/NCBI | |
|
Carr A, Wohlrab C, Young P and Bellomo R: Stability of intravenous vitamin C solutions: A technical report. Crit Care Resusc. 20:180–181. 2018.PubMed/NCBI |
